Value of Early Blood Th-1 Cytokine Determination in Predicting Severity of Acute Pancreatitis

REFERENCES

• Balthazar EJ, Ranson JHC, Naidich DP, Megibow AJ, Caccavale R, Cooper MM. Acute pancreatitis: prognostic value of CTl. Radiology;156:767–72.
   Google Scholar
• Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology 1986;91:433–8.
   PubMed Web of Science ®Google Scholar
• Gerzof SG, Banks PA, Spechler SJ, Johnson WC, Snider JM, Wetzmer SM, et al. Role of guided percutaneous aspiration in early diagnosis on pancreatic sepsis. Dig Dis Sci 1984;29:50–5.
   Web of Science ®Google Scholar
• Ranson JHC, Balthazar E, Caccavale R, Cooper M. Computed tomography and the prediction of pancreatic abscess in acute pancreatitis. Ann Surg 1985;201:656–65.
   PubMed Web of Science ®Google Scholar
• Rotman N, Bonhet E, Larde D, Fagniez PL. Diagnosis value of computerized tomography in the complication of acute pancreatitis. Am J Surg 1986;152:286–9.
   PubMed Web of Science ®Google Scholar
• Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L, Valtonen V, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995;346:663–7.
   PubMed Web of Science ®Google Scholar
• Finch WT, Sawyers JL, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Am Surg 1976;113:667–71.
   Google Scholar
• Yzet T, Delcenserie R. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas 1996;13:198–201.
   PubMed Web of Science ®Google Scholar
• Pederzoli P, Bassi C, Vesentini S. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993;176:480–3.
   Google Scholar
• Gerzof SG, Banks PA, Robbins AH. Early diagnosis of pancreatic infection by computed tomography-guided aspiration. Gastroenterology 1987;93:1315–20.
   Google Scholar
• Banks PA, Gerzof SG, Chong FK, Worthington MG, Doos WG, Sullivan JG, et al. Bacteriologic status of necrotic tissue in necrotizing pancreatitis. Pancreas 1990;5:330–3.
   PubMed Web of Science ®Google Scholar
• Hiatt JR, Fink AS, King W III. Percutaneous aspiration of peripancreatic fluid collections: a safe method to detect infection. Surgery 1987;101:523–30.
   Google Scholar
• Karimgani I, Porter KA, Langevin RE, Banks PA. Prognostic factors in sterile pancreatic necrosis. Gastroenterology 1992; 103:1636–40.
   PubMed Web of Science ®Google Scholar
• Bittner R, Block S, Buchler M, Beger HG. Pancreatic abscess and infected pancreatic necrosis: different local septic complications in acute pancreatitis. Dig Dis Sci 1987;32:1082–7.
   PubMed Web of Science ®Google Scholar
• Fink AS, Hiatt JR, Pitt HA, Bennion RS, De Souza LR, McCoy RD, et al. Indolent presentation of pancreatic abscess. Experience with 100 cases. Arch Surg 1988;123:1067–72.
   Google Scholar
• Lavigne L, Moreau J, Bertrand V, Escourrou J, Vaysse N, Frexinos J. Quelle fiabilite peut-on accorder aux critères biologiques dans revaluation précoce du pronostic d’une pancréatite aigue? [abstract]. Gastroenterol Clin Biol 1994;18:A94.17. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101: 782–5.
   Google Scholar
• Gross V, Scholmerich J, Leser HG, Salm R, Lausen M, Ruckauer K, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha1-antitrypsin, and protease inhibitor alpha2-macroglobulin. Dig Dis Sci 1990;35: 97–105.
   Google Scholar
• Iovanna JL, Keim V, Nordback I, Montalto G, Camarena J, Letoublon C, et al. Serum levels of pancreatitis-associated protein as indicators ot the course of acute pancreatitis. Gastroenterology 1994;106:728–34.
   PubMed Web of Science ®Google Scholar
• Vesentini S, Bassi C, Talamini G, Cavallini G, Campedelli A, Pederzoli P. Prospective comparison of C-reactive protein level, Ranson score and contrastenhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993;80:755–7.
   PubMed Web of Science ®Google Scholar
• Curley PJ, McMahon MJ, Lancaster F, Banks RE, Barclay GR, Shefta J, et al. Reduction in circulating levels of CD4positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 1993; 80:1312–5.
   PubMed Web of Science ®Google Scholar
• Viedma JA, Pérez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264–7.
   Google Scholar
• Viedma JA, Pérez-Mateo M, Agullo J, Dominguez JE, Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994;35:822–7.
   PubMed Web of Science ®Google Scholar
• Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41–5.
   PubMed Web of Science ®Google Scholar
• Pezzilli R, Billi P, Miniero R. Serum interleukin-6, interleukin-8, and β2-microglobulin in early assessment of severity of acute pancreatitis. Dig Dis Sci 1995;40: 2341–8.
   Google Scholar
• Bradley E. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586–90.
   PubMed Web of Science ®Google Scholar
• Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13–20.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Apache II: a severity of disease classification system. Crit Care Med 1985; 13:818–29.
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Loirat P, Alperovitch A. A simplified acute physiology score for ICU patients. Crit Care Med 1984;12:975–7.
   Google Scholar
• Bouillot JL, Mariette D, Canel MA, Gaudez F, Baccot S, Boucherie JC, et al. Pronostic vital dans la pancréatite aigue. Etude de 5 indices clinico-biologiques. Gastroenterol Clin Biol 1993;17:542–6.
   PubMedGoogle Scholar
• Imrie CW, Benjamin IS, Ferguson JC. A single-centre doubleblind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337–41.
   Google Scholar
• Blamey SL, Imrie CW, O’Neill J, Gilmour WH, Carter C. Prognostic factors in acute pancreatitis. Gut 1984;25:1340–6.
   Google Scholar
• Tran DD, Cuesta MA. Evaluation of severity in patients with acute pancreatitis. Am J Gastroenterol 1992;87:604–611.
   PubMed Web of Science ®Google Scholar
• Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331–6.
   PubMed Web of Science ®Google Scholar
• Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich P. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179–86.
   PubMed Web of Science ®Google Scholar
• Sironi M, Breviario F, Proserpio Biondi A, Vecchi A, Van Damme J, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989;142:549–53.
   PubMed Web of Science ®Google Scholar
• Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R. Interleukin-6 is the major regulator of acute phase protein systhesis in adult human hepatocytes. FEBS Lett 1989;242:237–9.
   PubMed Web of Science ®Google Scholar
• Coulie PG, Cayphas S, Vink A, Uyttenhove C, Van Snick J. Interleukin1-related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo. Eur J Immunol 1987;17:1217–20.
   Google Scholar
• Tanakori I, Makoto H, Tomihiro H, Hirotaka O, Tamaki Y, Hisashi Y, et al. Interleukin-6 a useful marker for early prediction of severity of acute pancreatitis. Pancreas 1997;14:1–8.
   PubMed Web of Science ®Google Scholar
• Gross V, Andreesen R, Leser HG. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22: 200–3.
   Google Scholar
• Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelletti O, Norselli-Labate M. Serum interleukin-6, interleukin-8, and B2 microglobulin in early assement of severity of acute pancreatitis. Dig Dis Sci 1995;40: 2341–8.
   Google Scholar
• Tosato G, Jones KD. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 1990;75:1305–10.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Walz A, Kunkel S. Neutrophil-activating peptide 1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84: 1045–9.
   Google Scholar
• Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991;87:463–9.
   PubMed Web of Science ®Google Scholar
• Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka–Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993;105: 1689–97.
   Google Scholar
• Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130:966–70.
   Google Scholar
• Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126–8.
   Google Scholar
• Tenner S, Sica G, Hughes M, Nordhoek E, Feng S, Zinner M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997;113:899–903.
   PubMed Web of Science ®Google Scholar
• Schindler BR, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;7:40–7.
   Google Scholar
• Marshall JB. Acute pancreatitis. A review with an emphasis on new developments. Arch Intern Med 1993;153:1185–98.
   PubMed Web of Science ®Google Scholar
• Heinisch A, Meßmann H, Ballé C, Kadow R, Bloss U, Mann S, et al. TNF-receptor levels as prognostic parameter in acute pancreatitis [abstract]. Digestion 1995;56:292.
   Google Scholar
• De Beaux AC, Goldie AS, Ross JA, Fearon KCH, Carter DC. Serum concentrations of tumor necrosis factor and its soluble receptors in patients with acute pancreatitis and their relationship to organ failure [abstract]. Digestion 1995;56:270.
   Google Scholar
• Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990;172:599–607.
   PubMed Web of Science ®Google Scholar
• Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323–9.
   Google Scholar
• VanZee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845–9.
   PubMed Web of Science ®Google Scholar
• Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992;90:533–6.
   Google Scholar
• Wallach D, Holtmann H, Aderka D, Rubinstein M, Avni YS, Sarov I, et al. Mechanisms which take part in regulation of the response to tumor necrosis factor. Lymphokine Res 1989;8:359.
   PubMedGoogle Scholar
• Norman J, Messina J, Franz M, Riker A, Fabri PJ, Rosemurgy AS, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis [abstract]. Gastroenterology 1994;106:A311.
   Web of Science ®Google Scholar
• Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991;88:1445–51.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. The proinflammatory cytokines and interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991;163:1177–84.
   PubMed Web of Science ®Google Scholar
• McIntyre KW, Stephan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Koffka KL, et al. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 1991;173:931–9.
   PubMed Web of Science ®Google Scholar
• Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990;85:1694–7.
   PubMed Web of Science ®Google Scholar
• Fischer E, VanZee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992;79:2196–200.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–73.
   PubMed Web of Science ®Google Scholar